132 related articles for article (PubMed ID: 30015928)
1. Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.
Shen W; Pang H; Xin B; Duan L; Liu L; Zhang H
Int J Oncol; 2018 Sep; 53(3):1354-1362. PubMed ID: 30015928
[TBL] [Abstract][Full Text] [Related]
2. The Biological Effects of Dickkopf1 on Small Cell Lung Cancer Cells and Bone Metastasis.
Pang H; Ma N; Jiao M; Shen W; Xin B; Wang T; Zhang F; Liu L; Zhang H
Oncol Res; 2017 Jan; 25(1):35-42. PubMed ID: 28081731
[TBL] [Abstract][Full Text] [Related]
3. MGr1-Ag promotes invasion and bone metastasis of small-cell lung cancer in vitro and in vivo.
Zhang F; Wang Y; Xu M; Dong H; Liu N; Zhou J; Pang H; Ma N; Zhang N; Pei Y; Zhang H; Liu L
Oncol Rep; 2013 Jun; 29(6):2283-90. PubMed ID: 23588894
[TBL] [Abstract][Full Text] [Related]
4. miR-335 inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways.
Gong M; Ma J; Guillemette R; Zhou M; Yang Y; Yang Y; Hock JM; Yu X
Mol Cancer Res; 2014 Jan; 12(1):101-10. PubMed ID: 23966614
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
[TBL] [Abstract][Full Text] [Related]
6. The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis.
Ma NQ; Liu LL; Min J; Wang JW; Jiang WF; Liu Y; Feng YG; Su HC; Feng YM; Zhang HL
Clin Exp Metastasis; 2011 Dec; 28(8):765-78. PubMed ID: 21785830
[TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic protein 7 in lung cancer and its biological impact on lung cancer cells.
Chen J; Ye L; Xie F; Yang Y; Zhang L; Jiang WG
Anticancer Res; 2010 Apr; 30(4):1113-20. PubMed ID: 20530416
[TBL] [Abstract][Full Text] [Related]
8. Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells.
Yang S; Zhong C; Frenkel B; Reddi AH; Roy-Burman P
Cancer Res; 2005 Jul; 65(13):5769-77. PubMed ID: 15994952
[TBL] [Abstract][Full Text] [Related]
9. Dll4-Fc, an inhibitor of Dll4-notch signaling, suppresses liver metastasis of small cell lung cancer cells through the downregulation of the NF-κB activity.
Kuramoto T; Goto H; Mitsuhashi A; Tabata S; Ogawa H; Uehara H; Saijo A; Kakiuchi S; Maekawa Y; Yasutomo K; Hanibuchi M; Akiyama S; Sone S; Nishioka Y
Mol Cancer Ther; 2012 Dec; 11(12):2578-87. PubMed ID: 22989420
[TBL] [Abstract][Full Text] [Related]
10. Μolecular impact of bone morphogenetic protein 7, on lung cancer cells and its clinical significance.
Liu Y; Chen J; Yang Y; Zhang L; Jiang WG
Int J Mol Med; 2012 Jun; 29(6):1016-24. PubMed ID: 22447022
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway.
Li X; Zhu W; Chen Z; Luo L; Huang J; Zhang F; Li M; Guo Y; Guo L
Anticancer Drugs; 2014 Nov; 25(10):1152-64. PubMed ID: 25054270
[TBL] [Abstract][Full Text] [Related]
12. BMP7 influences proliferation, migration, and invasion of breast cancer cells.
Alarmo EL; Pärssinen J; Ketolainen JM; Savinainen K; Karhu R; Kallioniemi A
Cancer Lett; 2009 Mar; 275(1):35-43. PubMed ID: 18980801
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
15. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of β3-integrin inhibits bone metastasis of small cell lung cancer.
Li N; Zhang JP; Guo S; Min J; Liu LL; Su HC; Feng YM; Zhang HL
Mol Biol Rep; 2012 Mar; 39(3):3029-35. PubMed ID: 21678053
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.
Hu W; Wei H; Li K; Li P; Lin J; Feng R
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28597490
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
[TBL] [Abstract][Full Text] [Related]
20. Organ-specific efficacy of HSP90 inhibitor in multiple-organ metastasis model of chemorefractory small cell lung cancer.
Takeuchi S; Fukuda K; Arai S; Nanjo S; Kita K; Yamada T; Hara E; Nishihara H; Uehara H; Yano S
Int J Cancer; 2016 Mar; 138(5):1281-9. PubMed ID: 26379118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
